Spots Global Cancer Trial Database for Safety Study of FLP Injection to Treat Tumor Patients
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Safety Study of FLP Injection to Treat Tumor Patients
Official Title: Phase 1 Study of FLP Injection on Tumor Patients
Study ID: NCT01361529
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to determine the tolerance and maximum tolerated dose (MTD) for FLP Injection with multiple dose in tumor patients.
Detailed Description: To determine the tolerance and MTD for FLP Injection with multiple dose in tumor patients. To test clinical pharmacokinetics (PK) and PK parameter
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
GCP center,First Affiliated Hospital of Zhejiang University, Hangzhou, Zhejiang, China
Contact Details
Name: jianying zhou, professor
Affiliation: First Affiliated Hospital of Zhejiang University
Role: PRINCIPAL_INVESTIGATOR
Name: nong xu, professor
Affiliation: First Affiliated Hospital of Zhejiang University
Role: PRINCIPAL_INVESTIGATOR
Name: jianzhong shentu, professor
Affiliation: First Affiliated Hospital of Zhejiang University
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
